| Pharyngeal Carcinoma studied in …STUDIED_INderived200 of 994show all (up to 200) |
|---|
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136196Phase 2 · recruiting BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05814549active not recruiting A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04671667Phase 2 · recruiting Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172245Phase 1 · recruiting Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07060261NA · recruiting Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Tonsillar Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565740Phase 1 · recruiting Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05172258Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07177443Phase 3 · recruiting Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824856Phase 2 · not yet recruiting Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029270Phase 2 · recruiting Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797881Phase 2 · not yet recruiting A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05880797recruiting Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07783321Phase 3 · not yet recruiting A Study of Anti-PD-1 Antibody With or Without BL-B01D1 as Maintenance Therapy Following Anti-PD-1 Antibody Plus Chemotherapy for the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma (PANKU-NPC02) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819656recruiting Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04255849Phase 3 · active not recruiting Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05721755Phase 3 · active not recruiting Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05752149Phase 2 · recruiting Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06064097Phase 2 · recruiting A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513389Phase 2 · recruiting Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818486Phase 1/Phase 2 · not yet recruiting A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055868active not recruiting People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02135042Phase 2/Phase 3 · active not recruiting Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513324Phase 2 · not yet recruiting Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812467Phase 2 · not yet recruiting Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07156227Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06761937Phase 1 · active not recruiting Thermotherapy for Locally Advanced Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06763289active not recruiting Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790966Phase 3 · terminated Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07625423Phase 1 · recruiting Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07690618Phase 1 · recruiting Thermotherapy for Head and Neck Cancer Patients · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810913Phase 2/Phase 3 · suspended Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787456recruiting "Xijiang Project" Screening Cohort for NPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796789Phase 3 · recruiting Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797738NA · not yet recruiting Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05126719Phase 2 · active not recruiting A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06976190Phase 3 · recruiting A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768189Phase 3 · not yet recruiting A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07794488Phase 2 · not yet recruiting Platinum-Free Regimen in Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03258554Phase 2/Phase 3 · completed Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07058805Phase 2 · recruiting Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137052recruiting Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201337Phase 3 · active not recruiting Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789158Phase 2 · not yet recruiting Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04456322Phase 3 · active not recruiting Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016920Phase 1/Phase 2 · recruiting Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784855NA · not yet recruiting Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck Cancer · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04910347Phase 2 · active not recruiting Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781358Phase 2 · recruiting Becotatug Vedotin Combined With a PD-1 Inhibitor in the Treatment of Locally Advanced Recurrent Nasopharyngeal Carcinoma. · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01893307Phase 3 · active not recruiting Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245682early Phase 1 · active not recruiting Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636499Phase 1 · active not recruiting Selective Neck Dissection Under Multimodal Assessment for N3 Nasopharyngeal Carcinoma After Radiotherapy · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336063Phase 1 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Keratinizing Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532279Phase 2 · recruiting Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07441681Phase 3 · recruiting Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04920344Phase 2 · active not recruiting Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07418034Phase 2 · not yet recruiting A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764887NA · not yet recruiting Impacted Tooth Management and Osteoradionecrosis Risk in NPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712888Phase 3 · active not recruiting Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07762976Phase 2 · recruiting Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609280Phase 2 · active not recruiting Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979961Phase 3 · active not recruiting Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05119036NA · completed Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915038NA · recruiting ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650266Phase 1 · not yet recruiting A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07756190Phase 2 · not yet recruiting Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04502407Phase 2 · active not recruiting Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900623Phase 2 · recruiting Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115772recruiting Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03803774Phase 1 · active not recruiting Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741110completed Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02567422Phase 1 · active not recruiting Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06947668recruiting Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172256Phase 2 · recruiting CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06854510Phase 2/Phase 3 · active not recruiting Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754321Phase 1 · recruiting Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Pharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06475300Phase 2 · recruiting A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07528183Phase 2 · recruiting Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419089Phase 2 · recruiting The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial) · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718620NA · recruiting HPV-associated Oropharyngeal Carcinoma (HPV-OPC) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07241273NA · not yet recruiting SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04852328Phase 2 · recruiting Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874493active not recruiting Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06662058NA · recruiting Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064902Phase 2 · not yet recruiting Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07665190Phase 2 · recruiting Neoadjuvant EGFR-ADC Combined With Anti-PD-1 Monoclonal Antibody in Resectable Locally Advanced Hypopharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07706985Phase 3 · recruiting Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799144Phase 2 · recruiting pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705243Phase 3 · recruiting Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858269Phase 2 · active not recruiting First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813626Phase 2 · active not recruiting Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692906NA · not yet recruiting Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797986Phase 1/Phase 2 · recruiting A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578467Phase 1/Phase 2 · not yet recruiting Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578727NA · not yet recruiting A Multicenter, Prospective, Phase III Clinical Study of Proton Intensity-modulated Radiotherapy Versus Photon Intensity-modulated Radiotherapy for Untreated Non-metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751486Phase 1 · completed A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788002Phase 2 · recruiting LDRT and Chemoimmunotherapy in NPC With Liver Metastasis · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07686575recruiting Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952585Phase 2/Phase 3 · active not recruiting De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05522881recruiting The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772706NA · completed Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07674706NA · not yet recruiting Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04151082Phase 1/Phase 2 · recruiting High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862650Phase 2 · active not recruiting Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050162Phase 2/Phase 3 · suspended Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04528394Phase 2 · completed Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05996523Phase 2 · active not recruiting Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592599Phase 2 · recruiting Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03097939Phase 2 · active not recruiting Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04965792active not recruiting Post-treatment Surveillance in HPV+ Oropharyngeal SCC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04533750Phase 1 · active not recruiting Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682442NA · recruiting Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494182Phase 2 · active not recruiting Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07303283Phase 2 · not yet recruiting Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06821243recruiting Patients With Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590024Phase 3 · recruiting RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628062Phase 2 · not yet recruiting Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618078recruiting Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04825990Phase 2 · active not recruiting Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05211232Phase 3 · active not recruiting Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145660Phase 3 · active not recruiting Optimization of Cervical Nodal CTV for Early and Medium Stage NPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910827Phase 1/Phase 2 · recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02254278Phase 2 · completed Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07325539Phase 2 · recruiting LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07497607Phase 2 · recruiting Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Pharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277050Phase 3 · recruiting Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584499Phase 1 · recruiting Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05541016Phase 2 · recruiting De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747390Phase 1 · recruiting Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852638Phase 2 · recruiting CD70-targeted immunoPET Imaging of Malignant Cancers · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581821Phase 2 · recruiting Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03930498Phase 2 · active not recruiting Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04436965Phase 3 · recruiting Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05340491Phase 3 · recruiting Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05780372Phase 3 · active not recruiting Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05941741Phase 3 · recruiting IC Plus Low-dose Radiation Plus Cadonilimab in LANPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06197776recruiting Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06323239Phase 2 · recruiting SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06802835Phase 1/Phase 2 · recruiting EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984861Phase 2 · recruiting A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997068Phase 2 · recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04425265NA · recruiting Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05294172Phase 3 · active not recruiting KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973386Phase 3 · completed Prognostic Analysis of Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy for Locally Advanced NPC Patients · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240835completed The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907826Phase 3 · recruiting PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201859Phase 2 · active not recruiting Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524168Phase 2 · active not recruiting SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07311772Phase 3 · recruiting Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03848286Phase 2 · completed KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600842recruiting De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07567742Phase 2 · not yet recruiting Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07013461recruiting International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07565389Phase 2 · not yet recruiting Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03799445Phase 2 · terminated Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944914Phase 3 · recruiting Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05531916NA · active not recruiting Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714657Phase 2 · active not recruiting Shortened Course Adjuvant Radiotherapy Following TORS · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555860Phase 2 · not yet recruiting Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04564989recruiting Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552883NA · not yet recruiting Pseudomembrane Removal for Post-RT Nasopharyngeal Necrosis · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633202Phase 3 · completed Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05108870Phase 1/Phase 2 · active not recruiting TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05268614Phase 2 · recruiting Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05491512Phase 2 · recruiting A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07548268NA · recruiting Transoral and Cervical Ultrasound of Patients With Suspected Oropharyngeal Cancer · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356272recruiting Oropharynx (OPX) Biomarker Trial · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07540390Phase 3 · not yet recruiting GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC. · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03621696Phase 2 · completed Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)" · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06118333Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01) · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03010150recruiting Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Hypopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870762Phase 2 · recruiting Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Tonsillar Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05232851Phase 1/Phase 2 · active not recruiting A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer · condition mapped CURATED_BROADER · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093061Phase 2 · recruiting Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323463Phase 2 · active not recruiting Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05307939Phase 2 · recruiting A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07423078Phase 2 · recruiting Window of Opportunity in Preserving Laryngeal Function Trial · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07496190Phase 2 · recruiting Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524413Phase 3 · not yet recruiting Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563480Phase 2 · completed TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483374recruiting The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers · condition mapped ALIAS · 994 trials mapped (422 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |